Seegene to Introduce Novel Real-Time PCR Technology at ASM Microbe 2016

Seegene to Introduce Novel Real-Time PCR Technology at ASM Microbe 2016 ? - Introducing a new SG oligo system which significantly saves assay development time and cost - Driving st...

Seegene Establishes Joint Venture in Mexico

- Seegene to provide advanced molecular diagnostic technologies and know-how to a Joint Venture in Mexico - Diversifying business to non-human in vitro diagnostic (IVD) markets such as those in a...

Seegene Technologies to Unleash Customized Multiplex PCR Solutions and Support for U.S. Market

Seegene Technologies to Unleash Customized Multiplex PCR Solutions and Support for U.S. Market Newly established innovation division at Seegene Technologies will deliver customized assays of i...

Seegene and BD Form Worldwide Collaboration to Develop Multiplex Molecular Diagnostic Assays

Seegene and BD Form Worldwide Collaboration to Develop Multiplex Molecular Diagnostic Assays Seoul, Korea, and Baltimore, MD, September 14, 2015 ---? Seegene Inc. (096530.KQ) and BD Life Scie...

Seegene and QIAGEN Enter into a Collaboration to Develop Multiplex Molecular Diagnostic Assay

Seoul, Korea, and Hilden, Germany, July 8, 2015 --- ?Seegene Inc. (096530.KQ), today announced that it has ?entered into aworldwide collaboration agreement with QIAGEN N.V. (NASDAQ: QGEN; Frankfurt...

Seegene to Attend ECCMID 2015 Annual Meeting

Seegene Establishes U.S. Subsidiary. Seegene Technologies Inc. to Drive Growth in the U.S. and Global Molecular Diagnostics Market

Seegene Establishes U.S. Subsidiary   Seegene Technologies Inc. to Drive Growth in the U.S. and Global Molecular Diagnostics Market CONCORD, CA and SEOUL, KOREA--(Market...

Seegene Receives Health Canada Approval for its new Allplex™ Respiratory Molecular Test

?Seegene Receives Health Canada Approval for its new Allplex™ Respiratory Molecular Test ? Gaithersburg, Maryland and SEOUL, Korea, March 2, 2015 ? Seegene Inc. (096530.KQ), a leading devel...

Seegene Receives FDA Clearance for its Herpes Simplex Virus Molecular Test

? Gaithersburg, Maryland and SEOUL, Korea, February17, 2015?Seegene Inc.(096530.KQ), a leading developer of multiplex PCR technologies, today announced that the U.S. Food and Drug Administratio...

Seegene to Present at the 33rd annual J.P. Morgan Healthcare Conference

Seegene to Present at the 33rd annual J.P. Morgan Healthcare Conference ?Gaithersburg, Maryland and SEOUL, Korea, January 5, 2014 ? Seegene Inc. (096530.KQ), a leading developer of multiplex ...

Seegene Introduces Allplex™ Assays Based on MuDT™ Next-Generation qPCR Technology

Seegene Submits First MDx to FDA with More Highly Multiplexed Test to Follow in 2015

Seegene to Unveil at AACC 2014 the Innovative Real-Time PCR Technology That Doubles the Channel Availability of Any Real-Time PCR Instrument

Seegene to unveil at AACC 2014 the innovative real-time PCR technology that doubles the channel availability of any real-time PCR instrument Gaithersburg, Maryland and SEOUL, Korea, July 22, 20...

Seegene Announces the World’s First Real-time PCR Technology for Multi-C_t in a Single Channel

 New "MDisc" technology breathes new life into real-time PCR by overcoming the challenge of "one channel, one Ct"   Gaithersburg, Maryland and SEOUL, Korea, May12, 2014 ?Seegene...